Harbor Investment Advisory LLC Decreases Stake in Shockwave Medical, Inc. (NASDAQ:SWAV)
Harbor Investment Advisory LLC Decreases Stake in Shockwave Medical, Inc. (NASDAQ:SWAV)
Harbor Investment Advisory LLC reduced its stake in Shockwave Medical, Inc. (NASDAQ:SWAV – Get Rating) by 15.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 378 shares of the company's stock after selling 70 shares during the period. Harbor Investment Advisory LLC's holdings in Shockwave Medical were worth $78,000 at the end of the most recent reporting period.
根據其最近向證券交易委員會（SEC）提交的文件，港灣投資諮詢有限責任公司在第四季度將其在衝擊波醫療公司（NASDAQ：SWAV-獲得評級）的股份減少了 15.6％。該公司於期內沽出 70 股股份後，擁有該公司股票的 378 股。海港投資諮詢有限責任公司在衝擊波醫療的持有價值 78,000 美元在最近的報告期結束時。
A number of other large investors have also bought and sold shares of SWAV. Tobam purchased a new position in Shockwave Medical in the 3rd quarter worth approximately $32,000. Trifecta Capital Advisors LLC purchased a new position in Shockwave Medical in the 4th quarter worth approximately $41,000. PenderFund Capital Management Ltd. bought a new stake in shares of Shockwave Medical in the 1st quarter worth approximately $41,000. Altshuler Shaham Ltd bought a new stake in shares of Shockwave Medical in the 3rd quarter worth approximately $58,000. Finally, Sentry Investment Management LLC bought a new stake in shares of Shockwave Medical in the 3rd quarter worth approximately $64,000. 90.56% of the stock is owned by hedge funds and other institutional investors.
一些其他大型投資者也買賣 SWAV 的股票。托巴姆在第三季度購買了衝擊波醫療的新職位，價值約 32,000 美元。三聯資本顧問有限責任公司購買了衝擊波醫療在第四季度的新位置，價值約 $41,000.彭德基金資本管理有限公司在第一季度購買了衝擊波醫療股份的新股份，價值約為 41,000 美元。阿爾特舒勒·沙漢姆有限公司在第三季度購買了衝擊波醫療股份的新股份，價值約為 58,000 美元。最後，哨兵投資管理有限責任公司在第三季度購買了衝擊波醫療股份的新股份，價值約為 64,000 美元。90.56％ 的股票由對沖基金和其他機構投資者擁有。
Insiders Place Their Bets
內部人士下注
In other Shockwave Medical news, insider Isaac Zacharias sold 4,000 shares of the business's stock in a transaction on Monday, March 27th. The stock was sold at an average price of $215.69, for a total value of $862,760.00. Following the sale, the insider now directly owns 74,078 shares of the company's stock, valued at $15,977,883.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, insider Isaac Zacharias sold 4,000 shares of the business's stock in a transaction on Monday, March 27th. The stock was sold at an average price of $215.69, for a total value of $862,760.00. Following the completion of the transaction, the insider now owns 74,078 shares in the company, valued at $15,977,883.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Frank T. Watkins sold 3,000 shares of the business's stock in a transaction on Friday, January 20th. The stock was sold at an average price of $176.29, for a total value of $528,870.00. Following the completion of the transaction, the director now owns 3,796 shares of the company's stock, valued at approximately $669,196.84. The disclosure for this sale can be found here. Over the last three months, insiders have sold 68,678 shares of company stock valued at $13,229,644. 3.90% of the stock is currently owned by corporate insiders.
在其他衝擊波醫療新聞中，內幕艾薩克·扎卡里亞斯（Isaac Zacharias）在 3 月 27 日（星期一）的一次交易中出售了該企業股票的 4,000 股。該股票以 215.69 美元的平均價格出售，總價值為 862,760 美元。出售後，內幕人士現在直接擁有該公司股票的 74,078 股，價值為 15,977,883.82 美元。該交易已在向證券交易委員會提交的文件中披露，該文件可在以下位置獲得： 此超連結。在其他消息中，內幕艾薩克·扎卡里亞斯（Isaac Zacharias）在 3 月 27 日星期一的交易中出售了 4,000 股該企業的股票。該股票以 215.69 美元的平均價格出售，總價值為 862,760 美元。交易完成後，內幕人士現在擁有該公司 74,078 股，價值為 15,977,883.82 美元。該交易在向證券交易委員會提交的文件中披露，可以通過以下方式訪問 證券交易所網站。此外，董事弗蘭克 ·T· 沃特金斯在 1 月 20 日（星期五）的一項交易中出售了該企業股票的 3,000 股。該股票以 176.29 美元的平均價格出售，總價值為 528,870.00 美元。交易完成後，董事現擁有該公司股票的 3,796 股股份，價值約為 669,196.84 美元。可以找到此次銷售的披露 這裡。在過去三個月中，內部人士已經出售了 68,678 股價值 13,229,644 美元的公司股票。3.90％ 的股票目前由企業內部人員擁有。
Shockwave Medical Trading Up 3.0 %
衝擊波醫療交易上升 3.0%
Shockwave Medical stock opened at $223.37 on Tuesday. The company has a current ratio of 7.25, a quick ratio of 6.06 and a debt-to-equity ratio of 0.05. The business's fifty day simple moving average is $195.70 and its two-hundred day simple moving average is $227.62. Shockwave Medical, Inc. has a 12 month low of $113.36 and a 12 month high of $320.54. The company has a market capitalization of $8.15 billion, a price-to-earnings ratio of 39.19 and a beta of 0.98.
衝擊波醫療股周二開盤為 223.37 美元。該公司的流動比率為 7.25，快速比率為 6.06，債務與權益比率為 0.05。該企業的五十天簡單移動平均線為 195.70 美元，其 200 天簡單移動平均線為 227.62 美元。衝擊波醫療有限公司擁有 12 個月低點 113.36 美元，創下 12 個月新高點 320.54 美元。該公司的市值為 815 億美元，39.19 的價格與收益比率和 0.98 的測試版。
Shockwave Medical (NASDAQ:SWAV – Get Rating) last released its earnings results on Thursday, February 16th. The company reported $3.71 EPS for the quarter, topping the consensus estimate of $0.99 by $2.72. Shockwave Medical had a return on equity of 59.99% and a net margin of 44.10%. The business had revenue of $144.00 million for the quarter, compared to the consensus estimate of $143.04 million. During the same period in the previous year, the company posted $0.34 earnings per share. The company's revenue for the quarter was up 71.0% compared to the same quarter last year. As a group, equities analysts predict that Shockwave Medical, Inc. will post 3.92 earnings per share for the current fiscal year.
衝擊波醫療（NASDAQ：SWAV-獲取評級）上次發布了其收益結果，週四，2 月 16 日。該公司報告了本季每股收益 3.71 美元，超過 0.99 美元的共識估計高出 2.72 美元。震波醫療的股本回報率為 59.99%，淨利潤率為 44.10%。該業務本季度的收入為 14,400 萬美元，而共識估計為 143.04 億美元。在上一年同期，該公司公佈了每股盈利 0.34 美元。與去年同期相比，該公司該季度的收入增長了 71.0%。作為一個集團，股票分析師預測，衝擊波醫療公司將在本財政年度公佈每股 3.92 盈利。
Wall Street Analysts Forecast Growth
華爾街分析師預測增長
A number of equities research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft assumed coverage on Shockwave Medical in a research report on Friday, December 16th. They issued a "buy" rating and a $285.00 price objective on the stock. Needham & Company LLC assumed coverage on Shockwave Medical in a research report on Wednesday, March 15th. They issued a "buy" rating and a $240.00 price objective on the stock. Piper Sandler cut their price objective on Shockwave Medical from $300.00 to $280.00 and set an "overweight" rating on the stock in a research report on Thursday, January 26th. Morgan Stanley cut their price objective on Shockwave Medical from $290.00 to $224.00 and set an "equal weight" rating on the stock in a research report on Friday, January 6th. Finally, Canaccord Genuity Group lifted their price objective on Shockwave Medical from $247.00 to $252.00 and gave the stock a "buy" rating in a research report on Friday, February 17th. One analyst has rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $247.40.
一些股票研究分析師最近對該公司進行了評級。德意志銀行行業務承擔衝擊波醫療上週五的研究報告覆蓋, 12 月 16 日.他們對股票發出了「買入」評級和 285.00 美元的價格目標。李約翰 & 公司有限責任公司承擔了衝擊波醫療上週三的研究報告覆蓋, 3 月 15 日.他們對股票發出了「買入」評級和 240.00 美元的價格目標。派珀桑德勒將衝擊波醫療的價格目標從 300.00 美元降至 280.00 美元，並在 1 月 26 日（星期四）的研究報告中設置了股票的「超重」評級。摩根士丹利將衝擊波醫療的價格目標從 290.00 美元降至 224.00 美元，並在 1 月 6 日（星期五）的研究報告中設定該股票的「同等權重」評級。最後，康雅克誠集團將衝擊波醫療的價格目標從 247.00 美元提高至 252.00 美元，並在 2 月 17 日（星期五）的一份研究報告中給予該股票「買入」評級。一位分析師對該股票進行了賣出評級，兩名分析師對該股票進行了保持評級，另外六名分析師對該股票發出了買入評級。根據市場節拍的數據，該股目前的共識評級為「中度買入」，平均目標價為 247.40 美元。
Shockwave Medical Company Profile
衝擊波醫療公司簡介
(Get Rating)
(取得評分)
Shockwave Medical, Inc operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease.
Shockwave Medical, Inc 是一家醫療器械公司，專注於開發和商業化旨在改變鈣化心血管疾病治療方式的產品。該公司提供用於治療膝蓋以上周邊動脈疾病的 M5 導管，用於治療冠狀動脈疾病的 C2 導管，以及 S4 導管或膝蓋以下周圍動脈疾病治療。
Featured Stories
特色故事
- Get a free copy of the StockNews.com research report on Shockwave Medical (SWAV)
- OPEC Slashes Production: The Start of a New Oil Bull Market?
- McDonald's Stock Breaks Higher and Could Have a Bigger Upside
- Can These 2 Pet Stocks Escape the Doghouse?
- Bellwether PPG Industries Raises Guidance, Stock Follows
- Mullen Automotive Building Momentum With Class-1 Vans
- 獲取有關衝擊波醫療研究報告的免費副本
- OPEC 大幅削減生產：新石油牛市的開始？
- 麥當勞的股票跌高，可能有更大的上漲空間
- 這兩隻寵物庫存能逃脫狗屋嗎？
- 貝爾韋瑟 PPG 行業提高指導，股票如下
- 馬倫汽車建築動力與一級廂式貨車
Want to see what other hedge funds are holding SWAV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shockwave Medical, Inc. (NASDAQ:SWAV – Get Rating).
想看看還有哪些對沖基金持有 SWAV？ 訪問 Holdingschannel.com 以獲取有關衝擊波醫療公司（NASDAQ：SWAV-獲取評級）的最新文件和內部交易。
Receive News & Ratings for Shockwave Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shockwave Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接收衝擊波醫療日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Shockwave 醫療和相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。